气道廓清技术对卒中相关肺炎患者疗效以及血清CGRP、MMP-9水平的影响

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2011 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of airway clearance technology on the curative effect and serum calcitoningene-relatedpeptide (CGRP) and matrix metalloprotein (MMP)-9 levels in patients with stroke related pneumonia. Methods 100 patients with stroke-related pneumonia treated in our hospital from June 2020 to December 2021 were selected as the research objects.100 patients were divided into experimental group and control group by random number table method, with 50 cases in each group. The patients in the control group were treated with routine treatment and intervention, and the patients in the experimental group were treated with airway clearance technology on the basis of the intervention measures in the control group. The curative effect, serum CGRP and MMP-9 levels were compared between the two groups. Results The effective treatment rate in the study group was 98.0%, which was significantly higher than that in the control group at 86.0%. Before the intervention, there were no significant differences between the two groups in terms of sputum expectoration, dyspnea scores, CPIS scores, CGRP levels, or MMP-9 levels. After the intervention, sputum expectoration scores, dyspnea scores, CPIS scores, and MMP-9 levels significantly decreased in both groups, while CGRP levels significantly increased. Additionally, the study group showed lower sputum expectoration scores, dyspnea scores, CPIS scores, and MMP-9 levels, and higher CGRP levels compared to the control group. Conclusion Airway clearance technology can significantly improve the curative effect of patients with stroke-related pneumonia, and significantly increase the level of serum CGRP and significantly decrease the level of MMP-9.

Key words： airway clearance technology stroke associated pneumonia curative effect calcitoningene-relatedpeptide matrix metalloprotein-9

Received: 18 July 2022

PACS:

R563.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CAO Xueping
	XIONG Chencheng
	ZHANG Wencai
	LI Xiaofang

Cite this article:

CAO Xueping,XIONG Chencheng,ZHANG Wencai等. Effect of airway clearance technique on curative effect and serum CGRP and MMP-9 levels in patients with stroke-related pneumonia[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2024, 21(5): 55-59.

URL:

http://yxb.hunnu.edu.cn/EN/ OR http://yxb.hunnu.edu.cn/EN/Y2024/V21/I5/55

[1] SANDLER N, HO H, DRAXLER D F, et al.Characterisation of Plasma Mitochondrial DNA, MMP-9 and Neutrophil Elastase in Patients Undergoing Coronary Artery Bypass Grafting: Effects of Tranexamic Acid and Postoperative Pneumonia.[J]. Heart Lung Circ, 2021: 92-93.
[2] LIU Y, LU HW, GU SY, et al.Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis[J]. EBioMedicine, 2021, 72: 103578.
[3] 罗红玲, 刘愿, 李楠楠, 等. 气道廓清技术对脑卒中吞咽障碍患者的康复效果[J]. 中国实用神经疾病杂志, 2021, 24(12): 1041-1047.
[4] 梁天佳, 莫明玉, 周开斌, 等. 气道廓清术在脑卒中相关性肺炎气管切开患者康复中的应用[J]. 中国呼吸与危重监护杂志, 2021, 20(4): 270-273.
[5] MCSHANE PJ, PHILLEY JV, PRIETO DA, et al.Global Attitudes of Health Care Providers About Aerosolized Airway Clearance Therapy in Bronchiectasis Patients During the Coronavirus 2019 Disease Pandemic.[J]. Chronic Obstr Pulm Dis, 2021 8(3): 319-325.
[6] LI D, YL, WANG T, , et al. Risk factors for stroke-related pneumonia in patients with ischaemic stroke: A systematic evaluation and meta-analysis[J]. Clin Neurol Neurosurg, 2024, 246: 108593.
[7] 郑月月, 倪朝民, 吴鸣, 等. 早期综合肺康复干预对有创机械通气患者呼吸机相关性肺炎的预防效果观察[J]. 中华物理医学与康复杂志, 2019, 41(6): 453-457.
[8] CHAUDARY N, BALASA G.Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care[J]. Int J Gen Med, 2021, 14: 102-103.
[9] 中国病理生理危重病学会呼吸治疗学组. 重症患者气道廓清技术专家共识[J]. 中华重症医学电子杂志, 2020, 06(00): E041.
[10] 中华医学会呼吸病学分会, 中国老年保健医学研究会呼吸病学分会, 中国呼吸医师分会呼吸职业发展委员会呼吸治疗师工作组, 等. 机械气道廓清技术临床应用专家共识[J]. 中华结核和呼吸杂志, 2023, 46(09): 866-879.
[11] POLLOCK BD, HERRIN J, NEVILLE MR, et al.Association of Do-Not-Resuscitate Patient Case Mix With Publicly Reported Risk-Standardized Hospital Mortality and Readmission Rates[J]. JAMA Netw Open, 2020, 3(7): e2010383.
[12] 朱建森, 成志锋, 李雨泽, 等. Ghrelin, CGRP, NT对胃肠作用的研究进展[J]. 现代生物医学进展, 2014, 14(16): 3191-3193+3197.
[13] 邱厚兵, 牟泽波, 刘育欣. 血清CGRP、MMP-9和T、NK细胞及免疫球蛋白对脑卒中并发肺部感染患者的诊断价值[J]. 中国微生态学杂志, 2019, 31(11): 1326-1331.
[14] 唐小波, 宋霜, 周胃雯, 等. 血清CGRP和MMP-9与PCT对卒中相关肺炎的诊断价值[J]. 中华医院感染学杂志, 2022, 32(03): 390-393.
[15] YAMAUCHI M, KINJO T, PARROTT G, , et al. Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia[J]. PloS one, 2020, 15(1): e0227636.
[16] CORTEN L, MORROW BM.Use of airway clearance therapy in children hospitalised with acute lower respiratory tract infections in a South African paediatric hospital[J]. S Afr J Physiother, 2020, 76(1): 1376.
[17] 霍希利, 李艳梅, 赵景明, 等. 前庭性偏头痛患者5-羟色胺、一氧化氮、基质金属蛋白酶-9、降钙素基因相关肽的临床意义分析[J]. 中国临床医生杂志, 2022, 50(1): 62-65.
[18] FINLAYSON O, KAPRAL M, HALL R.Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke[J]. Neurology, 2011, 77: 1338-1345.
[19] TAO B, JIANG L, CHEN L.Aberrant expression of calcitonin gene-related peptide and its correlation with prognosis in severe childhood pneumonia[J]. Clinics (Sao Paulo, Brazil), 2020, 75: e1448.
[20] ASHWIN B, RADMILA C, DOREEN ADDRIZZO-HARRIS, et al.Airway Clearance Techniques in Bronchiectasis[J]. Chest, 2020, 158(4): 1376-1384.
[21] 王国玉, 王义围, 王浩宇, 等. 经鼻高流量呼吸湿化氧疗对脑卒中相关肺炎患者血清炎性因子TNF-α及降钙素原指标的影响[J]. 解放军预防医学杂志, 2019, 37(7): 55-56.
[22] VOLPE MS, GUIMAR ES FS, MORAIS CC.Airway Clearance Techniques for Mechanically Ventilated Patients: Insights for Optimization[J]. Respiratory care, 2020, 65(8): 1174-1188.
[23] LEANGPANICH N, CHUPHANITSAKUN Y, PAKARANODOM K, et al.Scoring Of Post Stroke Pneumonia In Uttaradit Hospital[J]. J Multidiscip Healthc, 2019, 12: 917-923.
[24] 段霞, 侯景明, 洪健, 等. 脑卒中后吞咽障碍患者发生相关性肺炎的危险因素及预测模型分析[J]. 中国康复医学杂志, 2022, 37(5): 616-622.
[25] KISHORE AK, JEANS AR, GARAU J, et al.Antibiotic treatment for pneumonia complicating stroke: Recommendations from the pneumonia in stroke consensus (PISCES) group[J]. Eur Stroke J, 2019, 4(4): 318-328.